Search
-
Low awareness of GLP-1s globally, but high in the most advanced economies
Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.
-
Transforming Research Through Synthetic Data
Synthetic data, powered by AI, is poised to transform the market research industry. The question isn’t if, but when and how.
-
Ipsos Equalities Index 2025: More needs to be done to promote equality, but support has slipped over the last two years
The third edition of our Equalities Index covers 31 countries, and finds twice as many think campaigns to promote equality should go further (43%) than believe they ought to be rolled back (21%).
-
Ipsos Update – September 2025
Equality, Education, Wellness … Ipsos Update explores the latest research and thinking on key topics from Ipsos teams around the world.
-
Ipsos Rx Insight Store: Your On-Demand Hub for Healthcare Market Intelligence
Built on the foundation of Ipsos’ gold-standard Global Healthcare Monitors, the Ipsos Rx Insight Store offers standardised reports and dashboards that empower biopharma companies to make rapid, informed decisions for brand success.
-
Global Optimism Declines According to Ipsos Global Trends 9th Edition
Opportunities arise as economic adjustments and global dynamics reshape consumer optimism according to the 9th edition of Ipsos Global Trends.
-
Empathy: The new currency of Brand Connection
Isabelle Fortin shows how leveraging empathy-driven marketing can foster genuine connections with consumers and power creative effectiveness and brand success.
-
Climate Change and European Regulations in the European Union
Almost four-fifths (77%) believe large companies should be held accountable for environmental harms in their value chains.